Company intelligence
Sterne, Kessler, Goldstein & Fox
We're one of the most highly regarded intellectual property law firms in the world and a great place to work!
About Sterne, Kessler, Goldstein & Fox
Sterne, Kessler, Goldstein & Fox is a full-service intellectual property law firm that provides innovative solutions tailored to your business and industry. Since our founding in 1978, we have grown to become one of the largest IP specialty law firms in the United States. We collaborate across the full spectrum of IP to deliver real results for our clients—from patent and trademark prosecution, to patent litigation in federal district and appellate courts, strategic IP counseling, due diligence, and post-grant proceedings before the Patent Trial and Appeal Board. Our team includes attorneys, patent agents, and technical specialists with 100+ advanced degrees, including 60+ Ph.D.s,, in science and engineering disciplines. We work with the world’s leading innovators and brands, ranging from individual inventors and startups to renowned universities and Fortune 500 companies. We are proud to be one of the most highly regarded IP specialty law firms, and we have cultivated an environment that is welcoming, inclusive, and intellectually stimulating. And we’re honored that our attorneys and staff have voted Sterne Kessler as a Washington Post “Top Workplace” for 12 years running.
Verified activity
Signals from Sterne, Kessler, Goldstein & Fox
40 published signals
Research & Knowledge
Sterne, Kessler, Goldstein & Fox published an analysis by Sasha Rao and Ivy Clarice Estoesta examining the U.S. government's position on fair use for AI developers, copyright holders, and the legal landscape.
Reported by Sterne, Kessler, Goldstein & Fox
Research & Knowledge
Sterne, Kessler, Goldstein & Fox published an article in the Protecting Software with GUI Design Patents series discussing how a recently issued design patent offers an early look at how the USPTO's Supplemental Guidance for GUI-related design patents may apply beyond holographic, virtual reality, and augmented reality interfaces.
Reported by Sterne, Kessler, Goldstein & Fox
Research & Knowledge
Sterne, Kessler, Goldstein & Fox published an article titled When the Cloud Leaves Earth: Protecting Data Center Innovation in Orbit by Directors Ian Soule and Graham Phero exploring the emerging race to build data centers in orbit and patent, trade secret, and regulatory considerations.
Reported by Nirav Desai
Presence & Recognition
Sterne, Kessler, Goldstein & Fox is hosting a webinar on September 9, 2026, featuring David Holman, Jackie Wright Bonilla, and Ryan Estatico discussing recent AIA and EPR developments, technology-specific trends, practical guidance for parties, the impact of the new patent owner pre-order paper procedure, and updates on 35 U.S.C. § 325(d) and third-party EPR requests.
Reported by Ian Soule
Presence & Recognition
Sterne, Kessler, Goldstein & Fox director Paul Calvo will join industry leaders at the Life Science Legal Strategy Summit in Frankfurt, Germany, on Wednesday, October 14, 2026, to discuss clinical trial transparency requirements and patent strategies.
Reported by Jae Bandeh
Research & Knowledge
Sterne, Kessler, Goldstein & Fox published an article for Life Sciences IP Review by Director Paul Calvo examining how IP, data, and strategic assets influence biotech value creation and licensing.
Reported by Jae Bandeh
Research & Knowledge
Sterne, Kessler, Goldstein & Fox published an article for Life Sciences IP Review by Sterne Kessler Director Paul Calvo exploring how the rise of China-origin biotech assets is reshaping licensing conversations.
Reported by Sterne, Kessler, Goldstein & Fox
Research & Knowledge
Sterne, Kessler, Goldstein & Fox's Director Paul Calvo published an article for Life Sciences IP Review exploring how the rise of China-origin biotech assets is reshaping licensing conversations.
Reported by Ian Soule
Research & Knowledge
Sterne, Kessler, Goldstein & Fox published a client alert examining how the USPTO Appeals Review Panel interpreted the Federal Circuit's decision in Allergan v. MSN Laboratories, its guidance on the USPTO application of Allergan, and implications for patent prosecution strategy.
Reported by Nirav Desai
Research & Knowledge
Sterne, Kessler, Goldstein & Fox Director Paul Calvo published an article for Life Sciences IP Review exploring how the rise of China-origin biotech assets is reshaping licensing conversations.
Reported by Christopher Gallo
Research & Knowledge
Sterne, Kessler, Goldstein & Fox Director Paul Calvo published an article for Life Sciences IP Review exploring how the rise of China-origin biotech assets is reshaping licensing conversations.
Reported by Marsha Gillentine
Presence & Recognition
Sterne, Kessler, Goldstein & Fox directors Nirav Desai and Deborah Sterling are speaking at IP Litigation North America 2026 hosted by Kisaco Research at the Royal Sonesta Boston in September 14-16, 2026.
Reported by Christopher Gallo
Presence & Recognition
Sterne, Kessler, Goldstein & Fox is hosting a webinar on September 9, 2026, featuring David Holman, Jackie Wright Bonilla, and Ryan Estatico discussing recent AIA and EPR developments, technology-specific trends, practical guidance for parties, the impact of the new patent owner pre-order paper procedure, and updates on 35 U.S.C. § 325(d) and third-party EPR requests.
Reported by Christopher Gallo
Presence & Recognition
Sterne, Kessler, Goldstein & Fox is hosting a webinar on September 9, 2026, featuring David Holman, Jackie Wright Bonilla, and Ryan Estatico discussing recent AIA and EPR developments, technology trends, practical guidance, the impact of the new patent owner pre-order paper procedure, and updates on 35 U.S.C. § 325(d) and third-party EPR requests.
Reported by Sterne, Kessler, Goldstein & Fox
Presence & Recognition
Sterne, Kessler, Goldstein & Fox is hosting a webinar on September 9, 2026, featuring David Holman, Jackie Wright Bonilla, and Ryan Estatico discussing recent AIA and EPR developments, technology-specific trends, practical guidance for parties, the impact of the new patent owner pre-order paper procedure, and updates on 35 U.S.C. § 325(d) and third-party EPR requests.
Reported by Rich Coller
Presence & Recognition
Sterne, Kessler, Goldstein & Fox is hosting a webinar on September 9, 2026, featuring David Holman, Jackie Wright Bonilla, and Ryan Estatico discussing recent AIA and EPR developments, technology-specific trends, practical guidance for parties, the impact of the new patent owner pre-order paper procedure, and updates on 35 U.S.C. § 325(d) and third-party EPR requests.
Reported by Ryan Richardson
Presence & Recognition
Sterne, Kessler, Goldstein & Fox is hosting a webinar on September 9, 2026, featuring David Holman, Jackie Wright Bonilla, and Ryan Estatico discussing recent AIA and EPR developments, technology-specific trends, practical guidance for parties, the impact of the new patent owner pre-order paper procedure, and updates on 35 U.S.C. § 325(d) and third-party EPR requests.
Reported by Marsha Gillentine
Presence & Recognition
Sterne, Kessler, Goldstein & Fox Director David Holman spoke to MLex on how pharmaceutical companies are approaching psychedelic therapies and the intellectual property considerations that come with bringing these treatments to market.
Reported by Christopher Gallo
Presence & Recognition
Sterne, Kessler, Goldstein & Fox Director Jackie Wright Bonilla spoke with Law360 on the recent decision and brief from the U.S. Patent and Trademark Office regarding the complex doctrine of obviousness-type double patenting.
Reported by Christopher Gallo
Presence & Recognition
Sterne, Kessler, Goldstein & Fox directors Nirav Desai and Deborah Sterling are speaking at IP Litigation North America 2026 hosted by Kisaco Research at the Royal Sonesta Boston in September 14-16, 2026.
Reported by Jae Bandeh
Presence & Recognition
Sterne, Kessler, Goldstein & Fox director Paul Calvo will join industry leaders at the Life Science Legal Strategy Summit in Frankfurt, Germany, on Wednesday, October 14, 2026, to discuss clinical trial transparency requirements and patent strategies.
Reported by Christopher Gallo
Research & Knowledge
Sterne, Kessler, Goldstein & Fox published Part 3 of the Brand Protection Toolkit to Combat Dupes series by Em Richardson and Shana Olson exploring design patents as an enforcement tool against dupes.
Reported by Sterne, Kessler, Goldstein & Fox
Research & Knowledge
Sterne, Kessler, Goldstein & Fox published an article for Life Sciences IP Review by Director Paul Calvo examining how IP, data, and strategic assets influence biotech value creation and licensing.
Reported by Rich Coller
Presence & Recognition
Sterne, Kessler, Goldstein & Fox Director Jackie Wright Bonilla spoke with Law360 on the recent decision and brief from the U.S. Patent and Trademark Office regarding the complex doctrine of obviousness-type double patenting.
Reported by Ian Soule